Pure Global

Improving HbA1c Levels by Methylcobalamin Vitamin in Diabetic Volunteers - Trial NCT06241638

Access comprehensive clinical trial information for NCT06241638 through Pure Global AI's free database. This phase not specified trial is sponsored by Al-Balqa Applied University and is currently Completed. The study focuses on Diabetes Mellitus. Target enrollment is 80 participants.

This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.

Free Database
Powered by Pure Global AI
840K+ Trials
NCT06241638
Completed
drug
Trial Details
ClinicalTrials.gov • NCT06241638
View on ClinicalTrials.gov
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Improving HbA1c Levels by Methylcobalamin Vitamin in Diabetic Volunteers
Improving HbA1c Levels by Methylcobalamin Vitamin in Diabetic Volunteers, Combined With Dapagliflozin as Type Two Diabetes Mellitus Routine Treatment

Study Focus

Diabetes Mellitus

Vitamin B12 0.5 MG/ACTUAT

Interventional

drug

Sponsor & Location

Al-Balqa Applied University

Salt, Jordan

Timeline & Enrollment

N/A

Jul 01, 2022

Jun 30, 2023

80 participants

Primary Outcome

HbA1c in the two groups

Summary

The current study was conducted to evaluate the prognostic implications of vitamin B12
 admission on BMI and HbA1c levels in type 2 diabetic patients treated with Dapagliflozin as a
 routine medication.

ICD-10 Classifications

Diabetes mellitus
Unspecified diabetes mellitus
Other specified diabetes mellitus
Unspecified diabetes mellitus without complications
Unspecified diabetes mellitus with unspecified complications

Data Source

ClinicalTrials.gov

NCT06241638

Non-Device Trial